New Treatment for Cystic Fibrosis
-
- STATUS
- Not Recruiting
Updated on 15 April 2026
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF who are already taking Trikafta.
Details
| Condition | Cystic Fibrosis |
|---|---|
| Age | 18years - 65years |
| Clinical Study Identifier | TX17153 |
| Last Modified on | 15 April 2026 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.